Astera Labs, Inc. $ALAB Shares Sold by Atreides Management LP

Atreides Management LP cut its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 93.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 62,050 shares of the company’s stock after selling 892,733 shares during the quarter. Atreides Management LP’s holdings in Astera Labs were worth $12,149,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Ausdal Financial Partners Inc. lifted its holdings in shares of Astera Labs by 11.1% during the third quarter. Ausdal Financial Partners Inc. now owns 3,158 shares of the company’s stock valued at $618,000 after purchasing an additional 316 shares during the last quarter. Banco Bilbao Vizcaya Argentaria S.A. acquired a new position in shares of Astera Labs in the 3rd quarter valued at $1,810,000. Aquatic Capital Management LLC purchased a new position in Astera Labs in the 3rd quarter worth about $11,309,000. Algert Global LLC increased its stake in Astera Labs by 117.9% in the 3rd quarter. Algert Global LLC now owns 127,212 shares of the company’s stock worth $24,908,000 after purchasing an additional 68,822 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC raised its holdings in Astera Labs by 15.9% during the 3rd quarter. Schonfeld Strategic Advisors LLC now owns 11,784 shares of the company’s stock worth $2,307,000 after buying an additional 1,617 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CFO Michael Truett Tate sold 12,001 shares of the company’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $1,485,843.81. Following the transaction, the chief financial officer directly owned 192,083 shares of the company’s stock, valued at $23,781,796.23. This represents a 5.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jack R. Lazar sold 7,500 shares of the firm’s stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $119.80, for a total value of $898,500.00. Following the sale, the director directly owned 87,351 shares of the company’s stock, valued at $10,464,649.80. This trade represents a 7.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 224,292 shares of company stock worth $27,676,069 over the last 90 days. 12.50% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have commented on ALAB shares. Royal Bank Of Canada began coverage on shares of Astera Labs in a report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 target price for the company. Morgan Stanley restated an “overweight” rating and set a $210.00 price target on shares of Astera Labs in a report on Wednesday, December 3rd. Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. BNP Paribas Exane initiated coverage on shares of Astera Labs in a research note on Thursday, November 20th. They issued an “outperform” rating for the company. Finally, Citigroup lowered their price objective on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a research report on Wednesday, February 11th. Fifteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $202.22.

Astera Labs Price Performance

Shares of ALAB opened at $120.31 on Friday. The business’s 50-day moving average is $147.89 and its 200-day moving average is $168.11. The company has a market capitalization of $20.48 billion, a price-to-earnings ratio of 98.61, a P/E/G ratio of 2.37 and a beta of 1.74. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same period last year, the company posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.